Sequencing Immunotherapy in the Third-line and Beyond Setting for FL
Peter Martin, MD, discusses how to sequence bispecific T-cell engagers and CAR T-cell therapies in the third-line and beyond setting for FL.
Peter Martin Recent Updates Follicular Lymphoma Mantle Cell Lymphoma Beyond Setting Patient Preference
Source: onclive.com